Explore the words cloud of the LysoMod project. It provides you a very rough idea of what is the project "LysoMod" about.
The following table provides information about the project.
Coordinator |
INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES
Organization address contact info |
Coordinator Country | Portugal [PT] |
Project website | https://lysomod.wixsite.com/lysomod |
Total cost | 1˙156˙500 € |
EC max contribution | 1˙102˙500 € (95%) |
Programme |
1. H2020-EU.1.3.3. (Stimulating innovation by means of cross-fertilisation of knowledge) |
Code Call | H2020-MSCA-RISE-2016 |
Funding Scheme | MSCA-RISE |
Starting year | 2017 |
Duration (year-month-day) | from 2017-03-01 to 2021-02-28 |
Take a look of project's partnership.
LysoMod will innovate in the area of personalized medicine for disorders linked to lysosomal dysfunction. This will be achieved by implementing a collaborative staff-exchange program between highly complementary and multidisciplinary academic and non-academic partners with expertise in pharmacology, medicinal chemistry, cell biology, biochemistry, mouse and human genetics, transcriptomics, proteomics and lipidomics. Based on the critical role that lysosomes play in cells, a better understanding of lysosomal function will have a major impact on human health, fostering the development of new strategies to improve quality of life for people affected by a variety of diseases, ranging from lysosomal storage diseases (LSDs) to age-related neurodegenerative disorders. LysoMod’s specific objectives are: 1) to develop and further optimize existing therapies for LSDs; 2) to identify new targets for personalized therapies for LSDs; and 3) to investigate the cross-talk between lysosomal function, signalling pathways and gene expression regulation. The pioneer work of a participant in the consortium led to the development of a drug that is approved for clinical use. LysoMod will i) investigate the mechanisms of action of this and other drugs in lysosome-related disorder; ii) identify modifier genes involved in LSD pathology and test their potential as new targets for personalized therapeutic approaches; iii) identify candidate RNAs that can be targeted to enhance lysosomal function. The companies in the consortium will ensure a rapid transfer of new knowledge into applications for diagnostics and clinical trials. Prioritising lysosomal dysfunction as a highly relevant biomedical problem, the LysoMod consortium will implement a mentored staff-exchange program to provide young researchers with high-level training in innovative approaches for exploring biological systems, preparing the next generation of researchers for careers either in the private or public health sectors.
Organization of a summer school in Chile | Other | 2020-03-03 15:05:06 |
Project Website Internet-based social media | Websites, patent fillings, videos etc. | 2020-03-03 15:05:06 |
Take a look to the deliverables list in detail: detailed list of LysoMod deliverables.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LYSOMOD" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "LYSOMOD" are provided by the European Opendata Portal: CORDIS opendata.
Irradiation driven nanofabrication: computational modelling versus experiment
Read MoreVirtual tongue to predIct the oRganoleptic profile of mediterranean IngredienTs and their effect on hUman hOmeostasis by means of an integrated compUtational multiphysicS platform
Read MoreHemoglobin based Protein Nanocarriers for Tumour Oxygenation and a more effective Photodynamic Therapy
Read More